On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a ...

By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...

And GSK announced Thursday that the FDA had approved its medication gepotidacin, with the brand name Blujepa, as oral tablets ...

For the first time in nearly 40 years, the FDA approved a new antibiotic to treat gonorrhea, an STI that has grown ...

Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...

GlaxoSmithKline Pharmaceuticals Limited ( ($IN:GLAXO) ) has shared an update. GlaxoSmithKline Pharmaceuticals Limited has received an order from ...

The U.S. Food and Drug Administration said on Thursday it has expanded the use of GSK's Blujepa as an oral treatment for ...

The European Medicines Agency has recommended the approval of GSK's add-on drug to treat asthma and a chronic inflammatory ...

The boss of Britain’s largest drug developer has praised the US as the best place to invest amid fears over the waning appeal ...

Investing.com -- GSK plc (LSE:GSK) announced Friday that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the indication of its RSV ...